Physiol Rev Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Physiol. Rev. 81: 419-447, 2001;
0031-9333/01 $15.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (177)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Compston, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Compston, J. E.

Physiological Reviews, Vol. 81, No. 1, January 2001, pp. 419-447
Copyright ©2001 by the American Physiological Society

Sex Steroids and Bone

Juliet E. Compston

Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom

Compston, Juliet E. Sex Steroids and Bone. Physiol. Rev. 81: 419-447, 2001.Sex steroids are essential for skeletal development and the maintenance of bone health throughout adult life, and estrogen deficiency at menopause is a major pathogenetic factor in the development of osteoporosis in postmenopausal women. The mechanisms by which the skeletal effects of sex steroids are mediated remain incompletely understood, but in recent years there have been considerable advances in our knowledge of how estrogens and, to a lesser extent androgens, influence bone modeling and remodeling in health and disease. New insights into estrogen receptor structure and function, recent discoveries about the development and activity of osteoclasts, and lessons learned from human and animal genetic mutations have all contributed to increased understanding of the skeletal effects of estrogen, both in males and females. Studies of untreated and treated osteoporosis in postmenopausal women have also contributed to this knowledge and have provided unequivocal evidence for the potential of high-dose estrogen therapy to have anabolic skeletal effects. The development of selective estrogen receptor modulators has provided a new approach to the prevention of osteoporosis and other major diseases of menopause and has implications for the therapeutic use of other steroid hormones, including androgens. Further elucidation of the mechanisms by which sex steroids affect bone thus has the potential to improve the clinical management not only of osteoporosis, both in men and women, but also of a number of other diseases related to sex hormone status.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
P. Utriainen, J. Jaaskelainen, A. Saarinen, E. Vanninen, O. Makitie, and R. Voutilainen
Body Composition and Bone Mineral Density in Children with Premature Adrenarche and the Association of LRP5 Gene Polymorphisms with Bone Mineral Density
J. Clin. Endocrinol. Metab., November 1, 2009; 94(11): 4144 - 4151.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
E. Pollock, A.-E. Klotsas, J. Compston, and E. Gkrania-Klotsas
Bone health in HIV infection
Br. Med. Bull., October 29, 2009; (2009) ldp037v1.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
I. Mohamed and J. K Yeh
Alfacalcidol prevents aromatase inhibitor (Letrozole)-induced bone mineral loss in young growing female rats
J. Endocrinol., August 1, 2009; 202(2): 317 - 325.
[Abstract] [Full Text] [PDF]


Home page
IBMS BoneKEyHome page
L. E. Lanyon, T. Sugiyama, and J. S. Price
Regulation of Bone Mass: Local Control or Systemic Influence or Both?
IBMS BoneKEy, June 1, 2009; 6(6): 218 - 226.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
H. Wen, E. E. Bennett, M. M. Hegedus, and S. Rapacchi
Fourier X-ray Scattering Radiography Yields Bone Structural Information
Radiology, June 1, 2009; 251(3): 910 - 918.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-H. Yang, S. N. Sarkar, R. Liu, E. J. Perez, X. Wang, Y. Wen, L.-J. Yan, and J. W. Simpkins
Estrogen Receptor {beta} as a Mitochondrial Vulnerability Factor
J. Biol. Chem., April 3, 2009; 284(14): 9540 - 9548.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
Z. Rivera, P. J. Christian, S. L. Marion, H. L. Brooks, and P. B. Hoyer
Steroidogenic Capacity of Residual Ovarian Tissue in 4-Vinylcyclohexene Diepoxide-Treated Mice
Biol Reprod, February 1, 2009; 80(2): 328 - 336.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. D. Kim, D. E. Greenberg, M. E. Ehrmantraut, S. V. Guide, L. Ding, Y. Shea, M. R. Brown, M. Chernick, W. K. Steagall, C. G. Glasgow, et al.
Pulmonary Nontuberculous Mycobacterial Disease: Prospective Study of a Distinct Preexisting Syndrome
Am. J. Respir. Crit. Care Med., November 15, 2008; 178(10): 1066 - 1074.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. F. Yarrow, C. F. Conover, A. V. Purandare, A. M. Bhakta, N. Zheng, B. Conrad, M. K. Altman, S. E. Franz, T. J. Wronski, and S. E. Borst
Supraphysiological testosterone enanthate administration prevents bone loss and augments bone strength in gonadectomized male and female rats
Am J Physiol Endocrinol Metab, November 1, 2008; 295(5): E1213 - E1222.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. L. Jamieson, S. Shimizu, J. A. D'Ambrosio, O. Meucci, and A. Fatatis
CX3CR1 Is Expressed by Prostate Epithelial Cells and Androgens Regulate the Levels of CX3CL1/Fractalkine in the Bone Marrow: Potential Role in Prostate Cancer Bone Tropism
Cancer Res., March 15, 2008; 68(6): 1715 - 1722.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Merlet, C. Racine, E. Moreau, S. G. Moreno, and R. Habert
Male fetal germ cells are targets for androgens that physiologically inhibit their proliferation
PNAS, February 27, 2007; 104(9): 3615 - 3620.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
K. E S Poole and J. E Compston
Osteoporosis and its management
BMJ, December 16, 2006; 333(7581): 1251 - 1256.
[Full Text] [PDF]


Home page
Hum Mol GenetHome page
N. Rasheed, X. Wang, Q.-T. Niu, J. Yeh, and B. Li
Atm-deficient mice: an osteoporosis model with defective osteoblast differentiation and increased osteoclastogenesis
Hum. Mol. Genet., June 15, 2006; 15(12): 1938 - 1948.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. M. Tamimi, S. E. Hankinson, G. A. Colditz, and C. Byrne
Endogenous Sex Hormone Levels and Mammographic Density among Postmenopausal Women
Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2641 - 2647.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
W. Gao, P. J. Reiser, C. C. Coss, M. A. Phelps, J. D. Kearbey, D. D. Miller, and J. T. Dalton
Selective Androgen Receptor Modulator Treatment Improves Muscle Strength and Body Composition and Prevents Bone Loss in Orchidectomized Rats
Endocrinology, November 1, 2005; 146(11): 4887 - 4897.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
R. Massai, L. Makarainen, A. Kuukankorpi, C. Klipping, I. Duijkers, and T. Dieben
The combined contraceptive vaginal ring and bone mineral density in healthy pre-menopausal women
Hum. Reprod., October 1, 2005; 20(10): 2764 - 2768.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
E. Esposito, A. Iacono, G. M. Raso, M. Pacilio, A. Coppola, R. Di Carlo, and R. Meli
Raloxifene, a Selective Estrogen Receptor Modulator, Reduces Carrageenan-Induced Acute Inflammation in Normal and Ovariectomized Rats
Endocrinology, August 1, 2005; 146(8): 3301 - 3308.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
J. Chen, J. Kim, and J. T. Dalton
Discovery and Therapeutic Promise of Selective Androgen Receptor Modulators
Mol. Interv., June 1, 2005; 5(3): 173 - 188.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
L. Gennari, D. Merlotti, V. De Paola, A. Calabro, L. Becherini, G. Martini, and R. Nuti
Estrogen Receptor Gene Polymorphisms and the Genetics of Osteoporosis: A HuGE Review
Am. J. Epidemiol., February 15, 2005; 161(4): 307 - 320.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
F. F Bezerra, L. M. Mendonca, E. C Lobato, K. O O'Brien, and C. M Donangelo
Bone mass is recovered from lactation to postweaning in adolescent mothers with low calcium intakes
Am. J. Clinical Nutrition, November 1, 2004; 80(5): 1322 - 1326.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Muir, G. Romalo, L. Wolf, W. Elger, and H.-U. Schweikert
Estrone Sulfate Is a Major Source of Local Estrogen Formation in Human Bone
J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4685 - 4692.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
L. P. Mayer, P. J. Devine, C. A. Dyer, and P. B. Hoyer
The Follicle-Deplete Mouse Ovary Produces Androgen
Biol Reprod, July 1, 2004; 71(1): 130 - 138.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
D. Vanderschueren, L. Vandenput, S. Boonen, M. K. Lindberg, R. Bouillon, and C. Ohlsson
Androgens and Bone
Endocr. Rev., June 1, 2004; 25(3): 389 - 425.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Meier, P. Y. Liu, L. P. Ly, J. de Winter-Modzelewski, M. Jimenez, D. J. Handelsman, and M. J. Seibel
Recombinant Human Chorionic Gonadotropin But Not Dihydrotestosterone Alone Stimulates Osteoblastic Collagen Synthesis in Older Men with Partial Age-Related Androgen Deficiency
J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 3033 - 3041.
[Abstract] [Full Text] [PDF]


Home page
Sci Aging Knowl EnvironHome page
P. B. Hoyer
Can the Clock Be Turned Back on Ovarian Aging?
Sci. Aging Knowl. Environ., March 10, 2004; 2004(10): pe11 - pe11.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
M. Heim, O. Frank, G. Kampmann, N. Sochocky, T. Pennimpede, P. Fuchs, W. Hunziker, P. Weber, I. Martin, and I. Bendik
The Phytoestrogen Genistein Enhances Osteogenesis and Represses Adipogenic Differentiation of Human Primary Bone Marrow Stromal Cells
Endocrinology, February 1, 2004; 145(2): 848 - 859.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Moverare, J. Dahllund, N. Andersson, U. Islander, H. Carlsten, J.-A. Gustafsson, S. Nilsson, and C. Ohlsson
Estren Is a Selective Estrogen Receptor Modulator with Transcriptional Activity
Mol. Pharmacol., December 1, 2003; 64(6): 1428 - 1433.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
C. A. Thompson, T. D. Shanafelt, and C. L. Loprinzi
Andropause: Symptom Management for Prostate Cancer Patients Treated With Hormonal Ablation
Oncologist, October 1, 2003; 8(5): 474 - 487.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
V. Viereck, C. Grundker, S. Blaschke, B. Niederkleine, H. Siggelkow, K.-H. Frosch, D. Raddatz, G. Emons, and L. C. Hofbauer
Raloxifene Concurrently Stimulates Osteoprotegerin and Inhibits Interleukin-6 Production by Human Trabecular Osteoblasts
J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4206 - 4213.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Kawano, T. Sato, T. Yamada, T. Matsumoto, K. Sekine, T. Watanabe, T. Nakamura, T. Fukuda, K. Yoshimura, T. Yoshizawa, et al.
Suppressive function of androgen receptor in bone resorption
PNAS, August 5, 2003; 100(16): 9416 - 9421.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C. L Frankenfeld, R. E Patterson, N. K Horner, M. L Neuhouser, H. E Skor, T. F Kalhorn, W. N Howald, and J. W Lampe
Validation of a soy food-frequency questionnaire and evaluation of correlates of plasma isoflavone concentrations in postmenopausal women
Am. J. Clinical Nutrition, March 1, 2003; 77(3): 674 - 680.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Yeh, M.-Y. Tsai, Q. Xu, X.-M. Mu, H. Lardy, K.-E. Huang, H. Lin, S.-D. Yeh, S. Altuwaijri, X. Zhou, et al.
Generation and characterization of androgen receptor knockout (ARKO) mice: An in vivo model for the study of androgen functions in selective tissues
PNAS, October 15, 2002; 99(21): 13498 - 13503.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
E. F. Gevers, N. Loveridge, and I. C. A. F. Robinson
Bone Marrow Adipocytes: A Neglected Target Tissue for Growth Hormone
Endocrinology, October 1, 2002; 143(10): 4065 - 4073.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Sato, J. Vahle, A. Schmidt, M. Westmore, S. Smith, E. Rowley, and L. Y. Ma
Abnormal Bone Architecture and Biomechanical Properties with Near-Lifetime Treatment of Rats with PTH
Endocrinology, September 1, 2002; 143(9): 3230 - 3242.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Ueyama, N. Shirasawa, M. Numazawa, K. Yamada, M. Shelangouski, T. Ito, and Y. Tsuruo
Gastric Parietal Cells: Potent Endocrine Role in Secreting Estrogen as a Possible Regulator of Gastro-Hepatic Axis
Endocrinology, August 1, 2002; 143(8): 3162 - 3170.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
J. L. Vahle, M. Sato, G. G. Long, J. K. Young, P. C. Francis, J. A. Engelhardt, M. S. Westmore, Y. L. Ma, and J. B. Nold
Skeletal Changes in Rats Given Daily Subcutaneous Injections of Recombinant Human Parathyroid Hormone (1-34) for 2 Years and Relevance to Human Safety
Toxicol Pathol, April 1, 2002; 30(3): 312 - 321.
[Abstract] [PDF]


Home page
Recent Prog Horm ResHome page
P. M. Wise, M. J. Smith, D. B. Dubal, M. E. Wilson, S. W. Rau, A. B. Cashion, M. Bottner, and K. L. Rosewell
Neuroendocrine Modulation and Repercussions of Female Reproductive Aging
Recent Prog. Horm. Res., January 1, 2002; 57(1): 235 - 256.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online